Ascend Wellness Reports Q3 2026 Financial Results

NEW YORK – Ascend Wellness Holdings Inc. reported third quarter net revenue of $130 million, up 4.2% from a year earlier and 3.1% from the second quarter. Net loss widened to $28 million, compared with $25.8 million a year ago.

Aggressive store openings and stronger customer traffic carried the company’s growth during the quarter. The sales climbed 5.5% sequentially to $97.8 million, accounting for 75.2% of total revenue. Ascend logged roughly 1.7 million retail transactions – a company record propelled by a 37% annual surge in New Jersey store traffic and strong repeat business from loyalty program members. By contrast, external wholesale revenue slipped 3.6% from the previous quarter to $32.2 million, slowed by lower market pricing and a July work stoppage at its cultivation facility in Barry, Illinois.

Even with pricing pressure, operational discipline lifted profitability metrics before interest and taxes. Adjusted gross margin expanded to 48.4% from 46.2% in Q2 2026, while adjusted EBITDA rose to $31.1 million, representing a 23.9% margin.

AWH generated $5.4 million in operating cash flow and $2.7 million in free cash flow, even after making a twice yearly interest payment of $19.1 million. The company ended September with $63.6 million in cash against roughly $260.4 million in net debt and later closed $11 million in mortgage loans with CF Bank to fund further expansion.

Ascend Wellness closed the quarter with 56 dispensaries and has since reached 61 open locations, clearing its goal of 60 stores ahead of schedule. CEO Sam Brill told analysts that shifting volume toward company stores remains central to sustaining cash flow into 2027.

Beyond its domestic footprint across seven states, the company signed a licensing agreement with Atlantic Cultivation to introduce its Ozone and High Wired brands in Canada early next year. For Q4 2026, management projected modest sequential revenue growth of 1-2% alongside steady adjusted operating margins, an outlook that could leave full year revenue slightly below earlier analyst targets.

Viewed alongside broader industry trends, Ascend’s performance illustrates how MSOs are adapting to prolonged price compression. Expanding retail store counts and improving cultivation yields have allowed the company to protect operating margins and generate positive cash flow despite heavy borrowing costs. Still, with shareholders having authorized a reverse stock split to prepare for a potential uplisting to a major American exchange, long term valuation gains will rely on federal regulatory reform and sustained discipline in capital spending.